Divalproex Sodium Tablet, Extended Release
Product Images NDC 55111-534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55111-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Container (Container)

Container (Container)
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This text appears to be a mathematical formula showing the percentage reduction in CPS rate based on the dosage of Divalproex Sodium Delayed-Release Tablets. The formula shows the improvement percentage when high dose and low dose tablets are compared, with the percentage of patients included in the comparison.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.